MacLean AR - Search Results

1

Use of a "replication-restricted" herpes virus to treat experimental human malignant mesothelioma.

Kucharczuk JC, Randazzo B, Chang MY, Amin KM, Elshami AA, Sterman DH, Rizk NP, Molnar-Kimber KL, Brown SM, MacLean AR, Litzky LA, Fraser NW, Albelda SM, Kaiser LR. Kucharczuk JC, et al. Among authors: maclean ar. Cancer Res. 1997 Feb 1;57(3):466-71. Cancer Res. 1997. PMID: 9012475

2

Herpes simplex 1716--an ICP 34.5 mutant--is severely replication restricted in human skin xenografts in vivo.

Randazzo BP, Kucharczuk JC, Litzky LA, Kaiser LR, Brown SM, MacLean A, Albelda SM, Fraser NW. Randazzo BP, et al. Virology. 1996 Sep 15;223(2):392-5. doi: 10.1006/viro.1996.0493. Virology. 1996. PMID: 8806577 Free article.

3

Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant.

Kesari S, Randazzo BP, Valyi-Nagy T, Huang QS, Brown SM, MacLean AR, Lee VM, Trojanowski JQ, Fraser NW. Kesari S, et al. Among authors: maclean ar. Lab Invest. 1995 Nov;73(5):636-48. Lab Invest. 1995. PMID: 7474937

4

Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant.

Randazzo BP, Kesari S, Gesser RM, Alsop D, Ford JC, Brown SM, Maclean A, Fraser NW. Randazzo BP, et al. Virology. 1995 Aug 1;211(1):94-101. doi: 10.1006/viro.1995.1382. Virology. 1995. PMID: 7645240 Free article.

5

The HSV-1 latency associated transcript (LAT) variants 1704 and 1705 are glycoprotein C negative.

Wroblewska Z, Spivack JG, Otte J, Steiner I, Brown M, MacLean A, Fraser NW. Wroblewska Z, et al. Virus Res. 1991 Jul;20(2):193-200. doi: 10.1016/0168-1702(91)90109-9. Virus Res. 1991. PMID: 1659061

6

A herpes simplex virus type 1 variant, deleted in the promoter region of the latency-associated transcripts, does not produce any detectable minor RNA species during latency in the mouse trigeminal ganglion.

Mitchell WJ, Steiner I, Brown SM, MacLean AR, Subak-Sharpe JH, Fraser NW. Mitchell WJ, et al. Among authors: maclean ar. J Gen Virol. 1990 Apr;71 ( Pt 4):953-7. doi: 10.1099/0022-1317-71-4-953. J Gen Virol. 1990. PMID: 2157803

7

Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection.

Steiner I, Spivack JG, Lirette RP, Brown SM, MacLean AR, Subak-Sharpe JH, Fraser NW. Steiner I, et al. Among authors: maclean ar. EMBO J. 1989 Feb;8(2):505-11. doi: 10.1002/j.1460-2075.1989.tb03404.x. EMBO J. 1989. PMID: 2542019 Free PMC article.

8

Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 gamma 34.5 mutants in a mouse eye model.

Spivack JG, Fareed MU, Valyi-Nagy T, Nash TC, O'Keefe JS, Gesser RM, McKie EA, MacLean AR, Fraser NW, Brown SM. Spivack JG, et al. Among authors: maclean ar. J Gen Virol. 1995 Feb;76 ( Pt 2):321-32. doi: 10.1099/0022-1317-76-2-321. J Gen Virol. 1995. PMID: 7844554

9

The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice.

Valyi-Nagy T, Fareed MU, O'Keefe JS, Gesser RM, MacLean AR, Brown SM, Spivack JG, Fraser NW. Valyi-Nagy T, et al. Among authors: maclean ar. J Gen Virol. 1994 Aug;75 ( Pt 8):2059-63. doi: 10.1099/0022-1317-75-8-2059. J Gen Virol. 1994. PMID: 8046409

10

Peripheral replication and latency reactivation kinetics of the non-neurovirulent herpes simplex virus type 1 variant 1716.

Robertson LM, MacLean AR, Brown SM. Robertson LM, et al. Among authors: maclean ar. J Gen Virol. 1992 Apr;73 ( Pt 4):967-70. doi: 10.1099/0022-1317-73-4-967. J Gen Virol. 1992. PMID: 1321881

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page